Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMedOpen access

Conditioned medium from adipose mesenchymal stromal cells stimulated with pituitary adenylate cyclase-activating polypeptide (PACAP) mitigates RINm5F pancreatic β-cell dysfunction.

Oliva-Cárdenas A., Ávalos-Rodríguez A., Díaz-Rosas G., Cruz M., Nario-Chaidez HF., Contreras-Ramos A.

Animal Study on Immune Modulation, published in Mol Biol Rep (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Mol Biol Rep (2025)
Country
Netherlands
Reported sample size
—
Source database
PubMed
PMID
40632340
PMCID
PMC12241151
DOI
10.1007/s11033-025-10717-7
Citations
1

Abstract (original English)

Background The regenerative potential of mesenchymal stromal cells (MSCs) is linked to their secretion of bioactive molecules that modulate cellular processes. Different immunomodulatory molecules enhance their secretory and functional capacity. PACAP reduces oxidative stress and apoptosis, while promoting proliferation and cell differentiation. It also regulates inflammation and the immune response, but its role in MSCs secretoma modulation remains poorly explored. This study aimed to evaluate the effect of conditioned medium (CM) derived from PACAP -preconditioned MSCs on the recovery of β-pancreatic cells from the RINm5F line exposed to oxidative damage. Methods and results MSCs were obtained from adipose tissue of Sprague-Dawley rats. The concentration of PACAP to stimulate MSCs viability was determined by MTT assay. The mitochondrial metabolism of MSCs was significantly increased by PACAP at 0.1nM for 48 h. We evaluated the resulting CM protective effect in RINm5F cells exposed to oxidative damage by high glucose and streptozotocin (STZ). A dose-response curve was previously performed to select the CM concentration. Viability, mitochondrial membrane potential (MMP), radical oxygen species (ROS), apoptosis, glutathione peroxidase (GPx) activity and insulin secretion were all evaluated. RINm5F β-pancreatic cells treated with PACAP-preconditioned MSCs CM increased cells viabi

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AnimalsMesenchymal Stem CellsCulture Media, ConditionedRatsInsulin-Secreting CellsRats, Sprague-DawleyOxidative StressPituitary Adenylate Cyclase-Activating PolypeptideCell SurvivalApoptosis

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research